You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

Article metrics

Article menu

Download PDFPDF

XML
Pharmacology and therapeutics
Original research
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

 

Online download statistics by month:

Online download statistics by month: June 2020 to July 2022

AbstractFullPdf
Jun 2020228622701122
Jul 202018581855304
Aug 202016251613127
Sep 2020460457110
Oct 2020122120383
Nov 2020145138158
Dec 2020123122198
Jan 2021119110196
Feb 2021125121154
Mar 2021211209293
Apr 2021227222225
May 2021235227253
Jun 2021231221291
Jul 2021227224168
Aug 2021214213134
Sep 2021204200142
Oct 2021203324200
Nov 202120520596
Dec 2021365363112
Jan 2022219221167
Feb 2022219217142
Mar 2022374372189
Apr 2022292289136
May 2022272276128
Jun 2022229229101
Jul 2022443
Total10794108225532